On histopathology, the scalp tumor demonstrated an immunohistochemical profile supportive of an adenocarcinoma (pankeratin+, CEA+) with neuroendocrine differentiation (synaptophysin+) and hormonal receptor positivity (ER+, PR+, androgen receptor positivity). The gene discussed is NR4A1; the disease is adenocarcinoma.